U.S. Markets open in 7 hrs 48 mins

Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.56+0.59 (+3.11%)
At close: 4:00PM EST

Dyne Therapeutics, Inc.

830 Winter Street
Waltham, MA 02451
United States
781 786 8230

Full Time Employees36

Key Executives

NameTitlePayExercisedYear Born
Mr. Joshua T. BrummPres, CEO, Treasurer, Sec. & Director277.31kN/A1978
Dr. Romesh Subramanian Ph.D.Co-Founder & Chief Scientific Officer411.66kN/A1965
Dr. Jonathan McNeill M.D.VP of Bus. Devel.302.62kN/AN/A
Mr. Jason P. Rhodes M.B.A.Co-Founder & Independent ChairmanN/AN/A1970
Mr. Gene KimVP of Fin.N/AN/A1976
Ms. Susanna Gatti High M.B.A.Chief Operating OfficerN/AN/A1968
Mr. Richard ScalzoVP of Accounting & Admin.N/AN/A1986
Ms. Amy ReillyVP of Corp. Communications & Investor RelationsN/AN/A1973
Dr. Oxana Beskrovnaya Ph.D.Sr. VP & Head of ResearchN/AN/A1961
Dr. Thomas-Christian Mix M.D.Sr. VP of Clinical Devel.N/AN/A1967
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapies. The company was founded in 2017 and is based in Waltham, Massachusetts.

Corporate Governance

Dyne Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.